Get started Log in

DERM — Journey Medical Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Market Cap
$126.16m
Enterprise Value
$125.99m
Revenue
$61.86m

Brief: Journey Medical Corporation Enters Into An Exclusive License Agreement With Maruho Co., Ltd. For Qbrexza® In South Korea And Other Asian Nations
06/09/2023 16:17
Brief: Journey Medical Corp - On August 15, Received A Deficiency Letter From The Listing Qualifications Department Of The Nasdaq Stock Market Llc
18/08/2023 22:03
Journey Medical Corp reports results for the quarter ended in June - Earnings Summary
09/08/2023 24:20
Journey Medical Corp expected to post a loss of 33 cents a share - Earnings Preview
04/08/2023 23:24
Brief: Journey Medical Says Voluntarily Repaid About $10 Million Of Debt
26/07/2023 15:27
Brief: Journey Medical Corporation Expects Topline Results FromPhase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 For The Treatment Of Papulopustular Rosacea To Be Announced Week Of July 10
03/07/2023 13:12
U.S. STOCKS ON THE MOVE-Rio Tinto, BurgerFi International, Aclaris Therapeutics
13/06/2023 19:08
U.S. STOCKS ON THE MOVE-Comerica, copper miners, Journey Medical
13/06/2023 17:35
Journey Medical rises on positive early-stage data for skin disorder drug
13/06/2023 16:14
Brief: Journey Medical Corp Announces Topline Data From Phase 1 Clinical Trial Of DFD-29
13/06/2023 15:12
Brief: Journey Medical Reports Q1 Loss Of $0.57 Per Share
22/05/2023 22:48
Journey Medical Corp reports results for the quarter ended in March - Earnings Summary
22/05/2023 22:01
Brief: Journey Medical Corp Postponed Release Of Its First Fiscal Quarter Financial Results And Conference Call
11/05/2023 22:37
Journey Medical Corp expected to post a loss of 45 cents a share - Earnings Preview
10/05/2023 03:06
Journey Medical Corp reports results for the quarter ended in December - Earnings Summary
29/03/2023 22:02
Journey Medical Corp expected to post a loss of 47 cents a share - Earnings Preview
27/03/2023 21:45
Brief: Journey Medical Corporation Announces Completion Of Treatment Assessing Impact Of Dfd-29 (Minocycline Modified Release Capsules 40 Mg) On Microbial Flora In A Separate Phase 1 Clinical Trial
16/03/2023 13:13
Brief: Journey Medical Corp Appoints Interim CFO
20/01/2023 21:02
Journey Medical rises on completing enrollment in skin disorder drug trial
10/01/2023 18:52
Brief: Journey Medical Corp Completes Enrollment In Phase 3 Clinical Trials Evaluating Dfd-29 (Minocycline Modified Release Capsules 40 Mg) For Treatment Of Papulopustular Rosacea
10/01/2023 13:31